IFN-gamma up-regulates expression of the complement components C3 and C4 by stabilization of mRNA.
We investigated the mechanisms underlying the regulation of complement genes C3 and C4 by IFN-gamma. IFN-gamma (500 U/ml, 24 h incubation) increased steady state mRNA levels for both C3 and C4 in three different cell types (Hep G2, U937, and primary fibroblasts). The response to IFN-gamma in Hep G2 cells was time and dose dependent. At all doses of IFN-gamma and at all incubation times, the transcription rate for these two genes, determined by nuclear run-on assays, was reduced (0.3 +/- 0.1; unstimulated rate = 1.00). The t1/2 of mRNA for C3 and C4 in unstimulated cells was 1.8 +/- 0.3 and 2.2 +/- 0.2 h, respectively. After high-dose IFN-gamma stimulation, both C3 and C4 mRNA levels remained at 100% with respect to baseline at 5 h, but after 12 h, levels fell to 13 +/- 2% (C3) and 8 +/- 3% (C4) of baseline values, giving a half-life for these mRNA species of between 5 and 12 h. IFN-gamma stimulation increased C3 and C4 protein synthesis measured at 24 h. We suggest that it is the increase in mRNA stability that is the major effector mechanism by which IFN-gamma regulates C3 and C4 gene expression.
Mitchell
T J
TJ
Rheumatology Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.
Naughton
M
M
Norsworthy
P
P
Davies
K A
KA
Walport
M J
MJ
Morley
B J
BJ
D002460:Cell Line; D002478:Cells, Cultured; D003176:Complement C3 / Q000096:biosynthesis / Q000235:genetics*; D003181:Complement C4 / Q000096:biosynthesis / Q000235:genetics*; D004306:Dose-Response Relationship, Immunologic; D004355:Drug Stability; D006207:Half-Life; D006801:Humans; D007371:Interferon-gamma / Q000008:administration & dosage / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism*; D011994:Recombinant Proteins; D015854:Up-Regulation / Q000187:drug effects
D003176:Complement C3; D003181:Complement C4; D012333:RNA, Messenger; D011994:Recombinant Proteins; D007371:Interferon-gamma